USADA would like to remind all athletes that the 2016 Prohibited List went into effect on January 1, 2016. There have been some minor changes from the 2015 Prohibited List, and it is vitally important that all athletes take a moment to re-check any medication they are taking under the new 2016 Prohibited List.
A brief summary of the 2016 changes to the WADA Prohibited List can be found at http://ufc.usada.org/substances/prohibited-list/major-changes-2016-wada-prohibited-list/
Athletes can search medications purchased in the US, Canada, the United Kingdom and Japan to determine their prohibited status at: http://ufc.globaldro.com/
The full 2016 WADA Prohibited List can be downloaded at http://ufc.usada.org/wp-content/uploads/wada-2016-prohibited-list-en.pdf
As an example of a 2016 update, it is important to note that there have been new substances or clarifications added to the Prohibited List in various categories, including, but not limited to, meldonium (Mildronate) and insulin-mimetics, including all insulin-receptor agonists.
If an athlete has a legitimate medical need to use a substance or method on the 2016 WADA Prohibited List, they may apply for a Therapeutic Use Exemption (TUE). For more information on TUEs, see http://ufc.usada.org/substances/tue/
USADA has resources available to help. If an athlete has any questions regarding the prohibited status of a substance or method they can email email@example.com or call Athlete Express at 866-601-2632 (international toll free: +8008-120-8120).
This reminder is also available in the following languages.